{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:51:33Z","timestamp":1794307893914,"version":"4.9.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    Clonal mature plasmacytoid dendritic cell proliferations (MPDCP) are a recently recognized entity in the WHO fifth edition, but their pathologic spectrum remains poorly characterized. Cases with extensive MPDCP in the bone marrow (BM) are rare and can exhibit overlapping features with blastic plasmacytoid dendritic cell neoplasm (BPDCN). We compared clinicopathologic and genomic features of 11 patients with myeloid neoplasm-associated MPDCP to 5 patients with secondary BPDCN arising from clonally-related myeloid neoplasms. MPDCP exhibited variable degrees of BM involvement (5% to 50%) and architectural patterns, were uniformly positive for CD123, CD4, TCF4, and IRF8, variably positive for TCL1 (7\/11), CD5 (7\/11), and CD7 (2\/11), and negative for SOX4, CD56, and TdT. MPDCP skin involvement was rare (1\/11), with no CNS involvement. MPDCP heralded myeloid disease progression in a subset of patients, with increased blasts or progression to AML (4\/11). In contrast, secondary BPDCN was uniformly positive for SOX4 and TCL1, with frequent CD56 (4\/5) and subset\/weak TdT (3\/4). All BPDCN patients had characteristic skin lesions, and a subset with CNS involvement (2\/5). The underlying myeloid neoplasms associated with MPDCP or BPDCN were enriched in\n                    <jats:italic toggle=\"yes\">TET2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">SRSF2<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">ASXL1<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">RUNX1<\/jats:italic>\n                    , and RAS pathway mutations. While karyotypic abnormalities were uncommon in MPDCP, all BPDCN showed chromosomal structural abnormalities and copy number variants, including deletions of 3p, 9p, and 12p. Our findings expand the histopathologic, immunophenotypic, and genetic characterization of MPDCP, and highlight pathologic features that distinguish it from BPDCN. Utilization of SOX4 immunohistochemistry, combined with careful clinical and molecular correlation, can aid in resolving these diagnostic challenges.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002556","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:00:15Z","timestamp":1776704415000},"page":"872-882","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1755-6454","authenticated-orcid":false,"given":"Sarah J.","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4082-7622","authenticated-orcid":false,"given":"Christopher B.","family":"Hergott","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0185-1239","authenticated-orcid":false,"given":"Gabriel K.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7380-0226","authenticated-orcid":false,"given":"Andrew A.","family":"Lane","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2150-6732","authenticated-orcid":false,"given":"Marlise R.","family":"Luskin","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6756-261X","authenticated-orcid":false,"given":"Cecilia A.","family":"Larocca","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8264-834X","authenticated-orcid":false,"given":"Nicole R.","family":"LeBoeuf","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women\u2019s Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-9829","authenticated-orcid":false,"given":"Nana P.","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7245-9652","authenticated-orcid":false,"given":"Shai","family":"Shimony","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4527-5628","authenticated-orcid":false,"given":"Brianna F.","family":"Waller","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2023-6590","authenticated-orcid":false,"given":"Waihay J.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Department of Pathology, Northwestern University, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-0697","authenticated-orcid":false,"given":"Robert P.","family":"Hasserjian","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital, Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8699-2439","authenticated-orcid":false,"given":"Annette S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Department of Pathology, University of Michigan, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-9337","authenticated-orcid":false,"given":"Elizabeth A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2557-7415","authenticated-orcid":false,"given":"Sam","family":"Sadigh","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"key":"R1-20260715","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"R2-20260715","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/s41375-019-0447-3","article-title":"Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia","volume":"33","author":"Lucas","year":"2019","journal-title":"Leukemia"},{"key":"R3-20260715","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00000478-200405000-00004","article-title":"Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes\/interferon-producing cells associated with myeloid disorders","volume":"28","author":"Vermi","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R4-20260715","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00277-017-2947-4","article-title":"Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow\u202f: Summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016","volume":"96","author":"Tzankov","year":"2017","journal-title":"Ann Hematol"},{"key":"R5-20260715","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1182\/bloodadvances.2020002415","article-title":"Bone marrow dendritic cell aggregates associate with systemic immune dysregulation in chronic myelomonocytic leukemia","volume":"4","author":"Mangaonkar","year":"2020","journal-title":"Blood Adv"},{"key":"R6-20260715","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1600-0560.2011.01777.x","article-title":"Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm","volume":"38","author":"Dargent","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R7-20260715","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2020007897","article-title":"Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia","volume":"137","author":"Xiao","year":"2021","journal-title":"Blood"},{"key":"R8-20260715","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00428-017-2075-5","article-title":"Sharing of a PTPN11 mutation by myelodysplastic bone marrow and a mature plasmacytoid dendritic cell proliferation provides evidence for their common myelomonocytic origin","volume":"470","author":"Bodmer","year":"2017","journal-title":"Virchows Arch"},{"key":"R9-20260715","doi-asserted-by":"crossref","first-page":"903113","DOI":"10.3389\/fonc.2022.903113","article-title":"Case report: mature plasmacytoid dendritic cell proliferation associated with a lymphoid neoplasm","volume":"12","author":"Fei","year":"2022","journal-title":"Front Oncol"},{"key":"R10-20260715","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/bjh.18632","article-title":"Plasmacytoid dendritic cells in the setting of myeloid neoplasms: diagnostic guide to challenging pathologic presentations","volume":"200","author":"El Hussein","year":"2023","journal-title":"Br J Haematol"},{"key":"R11-20260715","doi-asserted-by":"crossref","DOI":"10.1007\/s00428-025-04333-w","article-title":"Plasmacytoid dendritic cell clusters are associated with poor prognosis in chronic myelomonocytic leukemia","author":"Kumar","year":"2025","journal-title":"Virchows Arch"},{"key":"R12-20260715","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/cyto.b.21932","article-title":"Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review","volume":"100","author":"Espasa","year":"2021","journal-title":"Cytometry Part B: Clinical Cytometry"},{"key":"R13-20260715","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1038\/s41375-021-01228-y","article-title":"Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin","volume":"35","author":"Batta","year":"2021","journal-title":"Leukemia"},{"key":"R14-20260715","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1080\/10428194.2020.1755856","article-title":"Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone","volume":"61","author":"Luskin","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"R15-20260715","doi-asserted-by":"crossref","first-page":"100352","DOI":"10.1016\/j.modpat.2023.100352","article-title":"Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with bone marrow","volume":"37","author":"Sadigh","year":"2023","journal-title":"Mod Pathol"},{"key":"R16-20260715","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1111\/j.1537-2995.2009.02170.x","article-title":"Immunophenotypical, morphologic, and functional characterization of maturation-associated plasmacytoid dendritic cell subsets in normal adult human bone marrow","volume":"49","author":"Mart\u00edn-Mart\u00edn","year":"2009","journal-title":"Transfusion"},{"key":"R17-20260715","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.18632\/oncotarget.4146","article-title":"Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile","volume":"6","author":"Mart\u00edn-Mart\u00edn","year":"2015","journal-title":"Oncotarget"},{"key":"R18-20260715","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/00000478-200207000-00003","article-title":"\u201cAgranular CD4+ CD56+ hematodermic neoplasm\u201d (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes","volume":"26","author":"Petrella","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R19-20260715","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/modpathol.2015.145","article-title":"Neoplasms derived from plasmacytoid dendritic cells","volume":"29","author":"Facchetti","year":"2016","journal-title":"Mod Pathol"},{"key":"R20-20260715","first-page":"1047","article-title":"Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm","volume":"106","author":"Wang","journal-title":"Haematologica 2021"},{"key":"R21-20260715","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/PAP.0b013e3181bb6bc2","article-title":"Plasmacytoid dendritic cells: physiologic roles and pathologic states","volume":"16","author":"Jegalian","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"R22-20260715","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ajcp\/aqac174","article-title":"Expanding the immunophenotypic spectrum of neoplastic and reactive plasmacytoid dendritic cells","volume":"159","author":"Wu","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"R23-20260715","doi-asserted-by":"crossref","first-page":"e87062","DOI":"10.1172\/jci.insight.87062","article-title":"Institutional implementation of clinical tumor profiling on an unselected cancer population","volume":"1","author":"Sholl","year":"2016","journal-title":"JCI Insight"},{"key":"R24-20260715","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of oncopanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Laborat Med"},{"key":"R25-20260715","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","article-title":"Validation and implementation of a custom next-generation sequencing clinical assay for hematologic malignancies","volume":"18","author":"Kluk","year":"2016","journal-title":"J Mol Diagn"},{"key":"R26-20260715","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1309\/UNM9TY9QJQNFFYTH","article-title":"Histologic and immunohistochemical study of bone marrow monocytic nodules in 21 cases with myelodysplasia","volume":"120","author":"Chen","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R27-20260715","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/modpathol.3800707","article-title":"Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology","volume":"19","author":"Orazi","year":"2006","journal-title":"Mod Pathol"},{"key":"R28-20260715","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1097\/PAS.0000000000001765","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias","volume":"45","author":"Katz","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R29-20260715","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/PAS.0000000000001874","article-title":"IRF8 is a reliable monoblast marker for acute monocytic leukemias, but does not discriminate between monoblasts and plasmacytoid dendritic cells","volume":"46","author":"Tzankov","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R30-20260715","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-023-06156-8","article-title":"Ultraviolet radiation shapes dendritic cell leukaemia transformation in the skin","volume":"618","author":"Griffin","year":"2023","journal-title":"Nature"},{"key":"R31-20260715","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/PAS.0000000000000156","article-title":"Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients","volume":"38","author":"Julia","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R32-20260715","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1038\/leu.2017.38","article-title":"Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin","volume":"31","author":"Brunetti","year":"2017","journal-title":"Leukemia"},{"key":"R33-20260715","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41408-018-0120-5","article-title":"Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms","volume":"8","author":"Patnaik","year":"2018","journal-title":"Blood Cancer J"},{"key":"R34-20260715","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.hoc.2020.01.003","article-title":"Cytogenetics of blastic plasmacytoid dendritic cell neoplasm: chromosomal rearrangements and DNA copy-number alterations","volume":"34","author":"Sakamoto","year":"2020","journal-title":"Hematol Oncol Clin North Am"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002556","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:48:38Z","timestamp":1786034918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002556","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}